William Aliski - Net Worth and Insider Trading
William Aliski Net Worth
The estimated net worth of William Aliski is at least $4 Million dollars as of 2024-09-20. William Aliski is the Director of Ultragenyx Pharmaceutical Inc and owns about 75,160 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $4 Million. William Aliski is also the Director of Applied Genetic Technologies Corp and owns about 8,500 shares of Applied Genetic Technologies Corp (AGTC) stock worth over $3,346. Details can be seen in William Aliski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William Aliski has not made any transactions after 2021-02-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William Aliski
William Aliski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Aliski owns 3 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , X4 Pharmaceuticals Inc (XFOR) , and Applied Genetic Technologies Corp (AGTC) .
Click here to see the complete history of William Aliski’s form 4 insider trades.
Insider Ownership Summary of William Aliski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2021-02-19 | director |
| XFOR | X4 Pharmaceuticals Inc | 2019-09-18 | director |
| AGTC | Applied Genetic Technologies Corp | 2021-11-30 | director |
William Aliski Latest Holdings Summary
William Aliski currently owns a total of 2 stocks. Among these stocks, William Aliski owns 75,160 shares of Ultragenyx Pharmaceutical Inc (RARE) as of February 19, 2021, with a value of $4 Million and a weighting of 99.92%. William Aliski also owns 8,500 shares of Applied Genetic Technologies Corp (AGTC) as of December 14, 2018, with a value of $3,346 and a weighting of 0.08%.
Latest Holdings of William Aliski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2021-02-19 | 75,160 | 58.77 | 4,417,153 |
| AGTC | Applied Genetic Technologies Corp | 2018-12-14 | 8,500 | 0.39 | 3,346 |
Holding Weightings of William Aliski
William Aliski Form 4 Trading Tracker
According to the SEC Form 4 filings, William Aliski has made a total of 4 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 7,500 shares on February 19, 2021, which brought William Aliski around $1 Million.
According to the SEC Form 4 filings, William Aliski has made a total of 0 transactions in Applied Genetic Technologies Corp (AGTC) over the past 5 years. The most-recent trade in Applied Genetic Technologies Corp is the acquisition of 6,000 shares on December 14, 2018, which cost William Aliski around $19,500.
Insider Trading History of William Aliski
- 1
William Aliski Trading Performance
GuruFocus tracks the stock performance after each of William Aliski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Aliski is 33.23%. GuruFocus also compares William Aliski's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Aliski within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William Aliski's insider trading performs compared to the benchmark.
Performance of William Aliski
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.31 | | | | | |
| Relative Return to S&P 500(%) | -3.64 | | | | | |
William Aliski Ownership Network
William Aliski Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
William Aliski is the director of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include director & 10 percent owner & President & CEO Emil D Kakkis , Controller and PAO Theodore Alan Huizenga , and EVP and General Counsel Karah Herdman Parschauer .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, William Aliski made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .
In summary, during the past 3 months, insiders sold 40,675 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 40,675 shares. During the past 18 months, 257,334 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 257,334 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
William Aliski Mailing Address
Above is the net worth, insider trading, and ownership report for William Aliski. You might contact William Aliski via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
